LLY
XNYSEli Lilly & Co.
Basic Materials · Pharmaceutical Preparations
$985.02
+17.09 (+1.77%)
15-min delayed
Drag to pan · Scroll to zoom · Hover for OHLC
Snapshot
Loading metrics…
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Employees
50,000
Country
US
IPO Date
1970-07-09
Recent News
Schrodinger Q1 Earnings Call Highlights
Yahoo · 5h ago
Alkermes plc Q1 2026 Earnings Call Summary
Yahoo · 10h ago
Lilly's Oral GLP-1 Pill Foundayo Starts Strong in Oral Obesity Market
Yahoo · 14h ago
AI Investment Activity to Surpass $650 Billion Annually as Enterprise Adoption Accelerates Toward 2026
Yahoo · 15h ago
Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show
Yahoo · 16h ago
Trade Tracker: Bill Baruch sells Thermo Fisher, trims Amgen and buys Eli Lilly
CNBC · 18h ago
Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality
Yahoo · 18h ago
Viking Therapeutics: Market Betting On Big Upside Through 2030
SeekingAlpha · 19h ago
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.